Stock Screener App

Frei -

Installieren

6.74

1.18% -0.06

Diamedica Therapeutics Inc (DMAC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	2.93% 5.822	5.656	6.47	4.983	3.928
Operating Income/Loss	1.68% -8.007	-8.144	-8.419	-6.883	-5.638
Nonoperating Income/Loss	29.12% 0.314	0.443	-	-	-
Income/Loss From Continuing Operations Before Tax	0.10% -7.693	-7.701	-7.891	-6.267	-5.112
Income Tax Expense/Benefit	0.00% 0.006	0.006	0.009	0.007	0.007
Income/Loss From Continuing Operations After Tax	0.10% -7.699	-7.707	-7.90	-6.274	-5.119
Net Income/Loss	0.10% -7.699	-7.707	-7.90	-6.274	-5.119
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.27% 42.96	42.84	0.8005	42.75	38.07
Basic Earnings Per Share	0.00% -0.18	-0.18	-0.18	-0.15	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.41

0.51%

GMAB

$28.83

0.42%

INCY

$100.47

1.20%

BNTX

$103.85

0.08%

ONC

$310.01

0.52%

INSM

$184.61

0.50%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters